innovation – Page 3

Dimension Secures $500M for Second Fund, Focusing on the Intersection of Science and Technology

9 months ago talkbio0Tagged Aortic Valve Insufficiency, biotech, Capital, Dimensions, innovation, Machine Learning, Science, Technology, venture

Dimension, Venture Capital, Science, Technology, Biotech, AI, Machine Learning, Life Sciences, Innovation

Empowering Women in Life Sciences: 2024’s Trailblazers in Biopharma R&D

10 months ago talkbio0Tagged 2024, Biological Science Disciplines, Biopharma, Fiercest, Gender, Health care facility, innovation, R&D, Women

Women in Life Sciences, Biopharma R&D, 2024’s Fiercest Women, Gender Balance, Innovation in Healthcare

AvenCell Therapeutics Secures $112 Million Series B Funding for Revolutionary ‘Switchable’ CAR-T Cell Therapy

11 months ago talkbio0Tagged AvenCell Therapeutics, biotech, CAR-T, CAR-Ts, Cell Therapy, Clinical Trials, innovation, Series B, Switchable

AvenCell Therapeutics, Series B Funding, CAR-T Cell Therapy, Switchable CAR-Ts, Clinical Trials, Biotech Innovation

Eli Lilly Expands Global Innovation Reach with New Research Centers in China

11 months ago talkbio0Tagged Biotechnology, China, Drug Development, Eli, Eli Lilly, Gateway, innovation, Research Organization

Eli Lilly, China, Research Centers, Innovation, Gateway Labs, Biotechnology, Drug Development

CMS Unveils Preliminary List of 101 Generic Drugs for Medicare $2 Out-of-Pocket Plan

11 months ago talkbio0Tagged Adherence (attribute), Drug List, Expenditures, Out-of-Pocket, Health Outcomes, innovation, Medicare, Myasthenic Syndromes, Congenital

Medicare $2 Drug List Model, generic drugs, out-of-pocket costs, medication adherence, health outcomes, CMS Innovation Center

Flagship’s Winning Streak Continues with Singapore R&D Partnership

11 months ago talkbio0Tagged Collaboration, Flagship, innovation, R&D, Singapore

Flagship, R&D collaboration, Singapore, biotech, innovation

Streamlining Drug Development: The Power of Phase-Appropriate Technology Transfers

12 months ago talkbio0Tagged CDMOs, Contract Development, Drug Development, innovation, manufacturing organizations, pharmaceutical manufacturing, Phase-Appropriate Technology Transfer, Regulatory Compliance, Technology Transfer

Technology Transfer, Phase-Appropriate Technology Transfer, Drug Development, Pharmaceutical Manufacturing, CDMOs (Contract Development and Manufacturing Organizations), Regulatory Compliance, Innovation in Drug Development

BIOSECURE Act Clears House Hurdle, Heads to Senate for Vote on Restricting Chinese Biotech Ties

1 year ago talkbio0Tagged BIOSECURE, Biotech Companies, Biotechnology, Chinese Language, Drug Industry, drug supply chain, innovation, National Security, Risk, Senate, United States, US House of Representatives, Voting

BIOSECURE Act, House of Representatives, Senate Vote, Chinese Biotech Companies, National Security Risks, U.S. Pharmaceutical Industry, Biotechnology Innovation, Drug Supply Chain